Browsing Tag
BSE Limited
141 posts
Urban Company (NSE: URBANCO) doubles InstaHelp peak orders in five months
Urban Company’s rapid-housekeeping platform has doubled its peak daily orders in about five months, strengthening its category lead while intensifying questions around pricing, retention and unit economics.
August 3, 2026
Indo-MIM IPO GMP points to ₹679 listing price, but is the market getting ahead of earnings?
Indo-MIM’s ₹194 grey market premium points to a possible ₹679 debut, but the IPO’s large offer-for-sale component and premium valuation demand a closer look.
July 22, 2026
Caliber Mining IPO allotment day: The 17% signal investors should not mistake for certainty
Caliber Mining IPO allotment follows 146.64-times demand as a 17% GMP fuels listing hopes, but debt and customer concentration remain key tests ahead.
July 22, 2026
ACME Solar (NSE: ACMESOLAR) locks in 20-year funding for 450MW/1.8GWh FDRE development
ACME Solar’s ₹2,646.64 crore REC loan funds a 450MW/1,800MWh peak-power project as investors weigh FDRE scale, debt, safety and delivery risk in India.
July 20, 2026
5paisa Capital (NSE: 5PAISA) Q1 profit rises 8% sequentially, but diluted EPS falls after Rs 468.8cr rights issue
5paisa Capital entered FY27 with a stronger balance sheet and higher income, although softer trading activity, slower customer acquisition and diluted earnings per share complicate the growth narrative.
July 17, 2026
CSM Technologies launches Rs 146cr IPO to fund working capital and debt reduction
CSM Technologies’ ₹146 crore IPO tests whether GovTech growth can outweigh customer concentration and cash-flow risks. Explore the valuation before listing.
June 24, 2026
Infosys expands GlobalFoundries AI mandate as #INFY trades near its 52-week low
Infosys expands its GlobalFoundries AI mandate as #INFY nears a 52-week low. Discover the deal’s strategic value, risks and investor implications.
June 24, 2026
Honasa Consumer buys 58% of Fluence Pharma: can #HONASA turn dermatologist trust into a nutraceuticals growth engine?
Honasa Consumer buys 58% of Fluence Pharma to enter nutraceuticals. Discover the valuation, growth logic and risks for #HONASA investors today. Read it now.
June 24, 2026
JSW Infrastructure (NSE: JSWINFRA) targets Rs 7,503cr institutional raise for ports, logistics and debt reduction
JSW Infrastructure’s ₹7,503 crore QIP backs port expansion, logistics and debt reduction. Find out if growth can outweigh #JSWINFRA dilution. Read more now.
June 24, 2026
GIC Re OFS at Rs 352 pushes #GICRE near its 52-week low: value opportunity or supply trap?
GIC Re’s ₹3,088 crore OFS pushed #GICRE near its 52-week low. Explore the earnings, valuation and future stake-sale risks. Read the analysis.
June 17, 2026